Priority Date: 11.01.12 (EP 20120000142)

NOVEL PSEUDOTYPED LENTIVIRAL PARTICLES AND THEIR USE IN THE IN VITRO TARGETED TRANSDUCTION OF UNDIFFERENTIATED PLURIPOTENT HUMAN EMBRYONIC STEM CELLS AND INDUCED PLURIPOTENT STEM CELLS

  • Application ID: EP13700169
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 2006
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Grund Intellectual Property Group is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Hoffmann Eitle PartmbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 151 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 11.01.2012 - Priority Date (EP 20120000142)
  • 18.07.2013 - Publication A1 (WO2013104728)
  • 19.11.2014 - Publication A1 (EP2802662)